Clinical Research Directory
Browse clinical research sites, groups, and studies.
EPI-STORM: Cytokine Storm in Organ Donors
Sponsor: Université de Sherbrooke
Summary
Kidney and liver transplantation are the treatment of choice and are often the last therapeutic option offered to patients with chronic renal and liver failure. More than 70% of kidneys and liver available for transplantation are obtained from donors following neurological death. Unfortunately, compared to living donation, transplant function, graft survival, and recipient survival are consistently inferior with kidneys and liver from neurologically deceased donors. This difference lies with the exacerbated pro-inflammatory state characteristic of deceased donors. Indeed, when neurologic death occurs, the immune system releases substances in the blood that could harm organs and particularly the liver and the kidneys. We believe that achieving a better understanding of the inflammatory processes of organ donors could be greatly informative to design future randomized controlled trial assessing the effect of personalized immunosuppressive therapy on organ donors to ultimately improve the care provided to donors so as to increase the number of organs available for transplantation and enhancing the survival of received grafts
Official title: EPI-STORM Cytokine Storm in Organ Donors: A Translational Study Linking Donor Epigenetic to Transplantation Success in Recipient
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
105
Start Date
2018-12-16
Completion Date
2025-12-01
Last Updated
2025-04-02
Healthy Volunteers
No
Interventions
No intervention
No intervention
Locations (4)
Hôpital Maisonneuve-Rosemont
Montreal, Quebec, Canada
Centre Hospitalier Universitaire de Montréal
Montreal, Quebec, Canada
Centre Hospitalier Universitaire de Québec- Université Laval
Québec, Quebec, Canada
CIUSSS de l'Estrie-CHUS
Sherbrooke, Quebec, Canada